Nautilus Biotechnology to Participate in B. Riley Securities’ Disruptive Biotech Enabling Technologies – Proteomics, Virtual Conference Mar 23, 2023 08:00AM
Macellum Nominates Ten Highly Qualified and Independent Candidates for Election to the Kohl’s Board (KSS) Feb 10, 2022 07:24AM
Macellum Nominates Ten Highly Qualified and Independent Candidates for Election to the Kohl’s Board of Directors Feb 10, 2022 07:00AM